Harnessing the power of four scientific disciplines, Starpax Biopharma Inc., a biopharmaceutical research and development company, has conceived a revolutionary platform technology to treat cancer.

Previous Amounts Raised: $60 million
Founder: Michel Gareau
Year Founded: 2017

Reg A+ offering made available through Starpax Biopharma. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. Please see the most recent Offering Circular for more information.

Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad.

Healthcare Leads Big Week Of Funding Rounds

Unlike the last few weeks, there were no nine-figure funding rounds this past week. But there were still plenty of head-turning deals that provided good vibes moving into the final months of the fourth quarter.

Healthcare companies were the big winners, but up-and-coming players in many other industries also got their hands on funding. Take a closer look at these rounds. 

Main Street Health secured $315 million led by Oak HC/FT. Based in Nashville and founded in 2021, this healthcare organization emphasizes rural America and partners with over 900 clinics. It's planning further expansion.

Pair Eyewear raised $75 million in a Series C round led by Prysm Capital. The New York-based customizable eyewear brand, founded in 2017, offers prescription glasses at $60 and has seen significant revenue growth.

Don’t Miss:

Shine Technologies locked in $70 million from investors like Baillie Gifford & Co. and Fidelity Investments. The Wisconsin-based company, founded in 2005, is at the forefront of fusion energy technology advancements.

Saronic Technologies received $55 million in a Series A funding round led by Caffeinated Capital. The Texas-based maritime autonomy firm, founded in 2022, focuses on advancing its autonomous surface vessels.

Capital Rx secured over $50 million from Atlantic Health System and Banner Health. The New York-based firm, established in 2017, offers a health platform called Judi and serves over 2.4 million members.

Mojo Vision raised $43.5 million in Series A from New Enterprise Associates and Khosla Ventures. Based in Saratoga, California, and founded in 2015, the company specializes in micro-LED development.

Harri attracted $43 million in Series B funding led by Atalaya Capital Management. Established in 2012, the New York-based firm offers an employee experience platform.

Stash Financial Inc. raised $40 million in a convertible note round. This New York-based investing app, founded in 2015, offers financial solutions for investors.

Prophecy secured $35 million in a Series B round led by Insight Partners and SignalFire. Based in Palo Alto, California, and founded in 2017, the company focuses on data platform development.

BlueNalu Inc. received $33.5 million in Series B from various investors. Established in 2017, this San Diego-based startup specializes in cellular aquaculture.

While you may not have the opportunity to invest in these companies right now, you're not out of luck. Through crowdfunding platforms, you can invest in the startups of today that will change the world of tomorrow.

If you're interested in healthcare startups, Starpax Biopharma is gaining ground. The company employs a cutting-edge blend of four scientific fields to pioneer a groundbreaking cancer treatment, using Magnetodrones to directly deliver anticancer drugs into tumors without entering the bloodstream, ensuring precise targeting and minimizing side effects. 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: StartupsStarpax Biopharma
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!